1954. Immunogenicity Against SARS CoV-2 Ancestral Strain and Variants of Two New COVID-19 Recombinant Adjuvanted Vaccines Compared to BNT162b2 As a Third Dose Following Two Doses of BNT162b2: a Single-Blinded Multicenter Randomized Controlled TrialOdile Launay,Marine Cachanado, Liem Binh Luong,Laetitia Ninove,Marie Lachâtre,Inès Ben Ghezala,Marc Bardou,Catherine Schmidt-Mutter,Karine Lacombe,Fabrice Laine,Jean-Sébastien Allain,Elisabeth Botelho-Nevers,Marie-Pierre Tavolacci,Christian Chidiac,Patricia Pavese,Bertrand Dussol,Stéphane Priet,Dominique Deplanque,Amel Touati,Laureen Curci,Eleine Konate,Nadine Ben Hamouda,Anissa Besbes,Eunice Nubret,Florence Capelle,Laurence Berard,Alexandra Rousseau,Eric Tartour,Tabassome Simon,Xavier De Lamballerie,Renaud Felten,Laure SURGERSOpen forum infectious diseases(2022)Cited 0|Views15No scoreAI Read ScienceMust-Reading TreeExampleGenerate MRT to find the research sequence of this paperChat PaperSummary is being generated by the instructions you defined